Blair William & CO Veracyte, Inc. Transaction History

Blair William & CO

$32 Billion
Q2 2024

A detailed history of Blair William & CO transactions in Veracyte, Inc. stock. As of the latest transaction made, Blair William & CO holds 15,704 shares of VCYT stock, worth $467,508. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,704

Previous 16,128 2.63%

Holding current value

$467,508

Previous $357,000 4.76%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$18.86 - $23.55 $7,996 - $9,985	-424 Reduced 2.63%	15,704 $340,000
Q1 2024 May 09, 2024	SELL	$21.0 - $29.1 $11,655 - $16,150	-555 Reduced 3.33%	16,128 $357,000
Q4 2023 Feb 12, 2024	SELL	$19.72 - $28.68 $470,775 - $684,677	-23,873 Reduced 58.86%	16,683 $458,000
Q3 2023 Nov 09, 2023	SELL	$22.33 - $29.92 $486,258 - $651,537	-21,776 Reduced 34.94%	40,556 $905,000
Q2 2023 Aug 11, 2023	SELL	$20.96 - $26.99 $30,119 - $38,784	-1,437 Reduced 2.25%	62,332 $1.59 Million
Q1 2023 May 12, 2023	SELL	$20.58 - $27.89 $66,699 - $90,391	-3,241 Reduced 4.84%	63,769 $1.42 Million
Q4 2022 Feb 10, 2023	SELL	$15.31 - $29.94 $49,451 - $96,706	-3,230 Reduced 4.6%	67,010 $1.59 Million
Q3 2022 Nov 09, 2022	BUY	$16.58 - $27.9 $454,805 - $765,324	27,431 Added 64.08%	70,240 $1.17 Million
Q2 2022 Aug 10, 2022	SELL	$15.45 - $29.52 $208,961 - $399,258	-13,525 Reduced 24.01%	42,809 $852,000
Q1 2022 May 13, 2022	SELL	$21.94 - $42.51 $448,716 - $869,414	-20,452 Reduced 26.64%	56,334 $1.55 Million
Q4 2021 Feb 14, 2022	BUY	$36.09 - $53.79 $44,354 - $66,107	1,229 Added 1.63%	76,786 $3.16 Million
Q3 2021 Nov 12, 2021	BUY	$35.62 - $52.97 $503,987 - $749,472	14,149 Added 23.04%	75,557 $3.51 Million
Q2 2021 Aug 12, 2021	SELL	$32.94 - $56.62 $182,322 - $313,391	-5,535 Reduced 8.27%	61,408 $2.46 Million
Q1 2021 May 13, 2021	BUY	$44.47 - $81.38 $1.19 Million - $2.19 Million	26,865 Added 67.03%	66,943 $3.6 Million
Q4 2020 Feb 09, 2021	SELL	$32.49 - $61.88 $129,472 - $246,591	-3,985 Reduced 9.04%	40,078 $1.96 Million
Q3 2020 Nov 06, 2020	BUY	$26.73 - $35.67 $218,972 - $292,208	8,192 Added 22.84%	44,063 $1.43 Million
Q2 2020 Aug 12, 2020	SELL	$19.49 - $28.11 $43,365 - $62,544	-2,225 Reduced 5.84%	35,871 $929,000
Q1 2020 May 11, 2020	SELL	$16.13 - $30.17 $108,345 - $202,651	-6,717 Reduced 14.99%	38,096 $926,000
Q4 2019 Feb 13, 2020	BUY	$20.78 - $29.99 $412,753 - $595,691	19,863 Added 79.61%	44,813 $1.25 Million
Q3 2019 Nov 12, 2019	BUY	$23.87 - $30.93 $59,675 - $77,325	2,500 Added 11.14%	24,950 $599,000
Q2 2019 Aug 13, 2019	BUY	$22.1 - $28.56 $159,120 - $205,632	7,200 Added 47.21%	22,450 $640,000
Q4 2018 Feb 14, 2019	SELL	$9.15 - $14.85 $9,150 - $14,850	-1,000 Reduced 6.15%	15,250 $192,000
Q3 2018 Nov 13, 2018	BUY	$9.55 - $12.64 $9,550 - $12,640	1,000 Added 6.56%	16,250 $155,000
Q2 2018 Aug 13, 2018	SELL	$5.39 - $9.66 $35,574 - $63,756	-6,600 Reduced 30.21%	15,250 $142,000
Q4 2017 Feb 14, 2018	BUY	$6.05 - $9.37 $132,192 - $204,734	21,850	21,850 $143,000

Others Institutions Holding VCYT

# of Institutions

254

Shares Held

82.1M

Call Options Held

42.3K

Put Options Held

18.2K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.13B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account